Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1
Research output: Contribution to journal › Journal article › Research › peer-review
Original language | English |
---|---|
Journal | Diabetic Medicine |
Volume | 19 |
Issue number | 9 |
Pages (from-to) | 790-2 |
Number of pages | 3 |
ISSN | 0742-3071 |
Publication status | Published - Sep 2002 |
- Adult, Amyloid, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glucagon, Glucagon-Like Peptide 1, Humans, Hyperglycemia, Hypoglycemic Agents, Islet Amyloid Polypeptide, Male, Peptide Fragments, Protein Precursors
Research areas
ID: 132056414